TSC1 and prostate carcinoma: As overexpression of AKT3 decreased protein level of TSC1 and TSC2, we hypothesized that knockdown of TSC1 (Figure 11A) or TSC2 (Figure 11B) will enhance proliferation of prostate cancer cells.